Relay Therapeutics Inc (RLAY)
3.05 x 6 3.10 x 1
Post-market by (Cboe BZX)
3.10 -0.16 (-4.91%) 04/29/25 [NASDAQ]
3.05 x 6 3.10 x 1
Post-market 3.10 -0.00 (-0.06%) 18:26 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | RLAY | AKBA | SVRA | ||
| Company | Relay Therapeutics Inc | Akebia Therapeutics | Savara Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.33 | 2.43 | 3.15 | ||
| High | 3.33 | 2.48 | 3.29 | ||
| Low | 3.04 | 2.37 | 3.15 | ||
| Last | 3.10 | 2.43 | 3.26 | ||
| Change | -0.16 | unch | +0.07 | ||
| % Change | -4.91% | unch | +2.19% | ||
| Volume | 1,541,100 | 2,821,500 | 373,500 | ||
| 20-Day Average Volume | 2,716,420 | 4,059,960 | 720,640 | ||
| Previous Close | 3.26 | 2.43 | 3.19 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.62 | 1.97 | 2.97 | ||
| 20-Day Raw Stochastic | 85.26% | 94.79% | 85.55% | ||
| 20-Day Relative Strength | 51.72% | 63.11% | 61.07% | ||
| Weighted Alpha | -59.60 | +55.91 | -19.98 | ||
| Today's Opinion | 56% Sell | 56% Buy | 8% Buy | ||
| Previous Opinion | 56% Sell | 56% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Sell | 40% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.80% since 04/22/25 | +13.55% since 04/22/25 | +1.24% since 04/22/25 | ||
| Low | 2.96 on 04/23/25 | 2.15 on 04/24/25 | 3.14 on 04/28/25 | ||
| High | 3.33 on 04/29/25 | 2.48 on 04/29/25 | 3.38 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +13.97% since 03/28/25 | +27.23% since 03/28/25 | +12.03% since 03/28/25 | ||
| Low | 1.77 on 04/07/25 | 1.52 on 04/10/25 | 2.52 on 04/09/25 | ||
| High | 3.33 on 04/29/25 | 2.48 on 04/29/25 | 3.38 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -30.80% since 01/29/25 | +5.65% since 01/29/25 | +22.10% since 01/29/25 | ||
| Low | 1.77 on 04/07/25 | 1.52 on 04/10/25 | 2.26 on 03/04/25 | ||
| High | 4.86 on 02/05/25 | 2.89 on 03/19/25 | 3.38 on 04/23/25 | ||
| 6-Month | |||||
| %Chg | -47.46% since 10/29/24 | +42.11% since 10/29/24 | -11.41% since 10/29/24 | ||
| Low | 1.77 on 04/07/25 | 1.52 on 04/10/25 | 2.26 on 03/04/25 | ||
| High | 6.50 on 11/06/24 | 2.89 on 03/19/25 | 4.30 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 555,794 | 574,041 | 550,699 | ||
| Shares Outstanding, K | 170,489 | 236,231 | 172,633 | ||
| Annual Sales | 10,010,000 | 160,180,000 | 0 | ||
| Annual Net Income | -337,710,000 | -69,410,000 | -95,880,000 | ||
| Last Quarter Sales | 0 | 46,500,000 | 0 | ||
| Last Quarter Net Income | -76,000,000 | -22,800,000 | -29,040,000 | ||
| 60-Month Beta | 1.70 | 0.87 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 02/26/25 | -0.10 on 03/13/25 | -0.13 on 03/27/25 | ||
| Latest Earnings Date | 05/01/25 | 05/08/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||